scanX
J B Chemicals and Pharmaceuticals
add_icon

J B Chemicals and Pharmaceuticals

1,905.90
+23.20
(1.23%)
Market Cap
29,856.11 Cr
PE Ratio
40.12
Volume
20,430.00
Day High - Low
1,906.30 - 1,883.50
52W High-Low
1,939.00 - 1,385.75
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
29,856.11 Cr
EPS
42.45
PE Ratio
40.12
PB Ratio
7.95
Book Value
231.94
EBITDA
1,070.20
Dividend Yield
0.80 %
Industry
Healthcare
Sector
Pharmaceuticals
Return on Equity
19.21
Debt to Equity
0.06
Analyst Rating and Forecast
- By Refinitiv from9 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+55.56 %
+55.56 %
Hold
Hold+44.44 %
+44.44 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
J.B. Chemicals VP-Legal Himanshu Ranvah Resigns2 days ago
J.B. Chemicals & Pharmaceuticals announces resignation of Vice President-Legal Himanshu Ranvah effective February 6, 2026, with smooth transition planned to Mr. Vishal Chavan.
neutral
JB Chemicals Senior Management Resignations4 days ago
J.B. Chemicals & Pharmaceuticals Limited announces resignations of two senior executives - President Operations and President India Business, effective March 5, 2026.
positive
JB Chemicals Sets Record Date for Interim Dividend4 days ago
J.B. Chemicals & Pharmaceuticals Limited has fixed February 11, 2026 as the record date for determining shareholder eligibility for interim dividend for FY 2025-2026.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,716.80
#1 4,11,917.83
37.34
#1 54,729.00
9.71
#1 10,980
16.07
55.32
Divis Laboratories
6,193.00
1,64,404.69
65.34
9,712.00
18.67
2,191
35.10
46.83
Torrent Pharmaceuticals
4,051.50
1,37,121.17
63.19
11,539.40
6.99
1,911
30.46
53.95
Cipla
1,343.30
1,08,507.99
23.92
28,409.50
7.12
5,291
-57.18
37.12
Dr Reddys Laboratories
1,262.10
1,05,338.70
19.27
33,741.20
16.73
5,725
-15.28
62.03
Lupin
2,219.50
1,01,386.49
23.11
22,909.50
13.74
3,306
#1 72.75
57.64
Zydus Life Science
894.65
90,022.72
#1 18.48
23,511.00
18.55
4,615
-0.32
59.51
Mankind Pharma
2,077.40
85,756.13
47.68
12,744.20
#1 20.90
2,007
7.65
44.00
Aurobindo Pharma
1,202.00
69,812.36
20.39
32,345.60
9.43
3,484
7.59
54.54
Alkem Laboratories
5,758.50
68,851.51
28.51
13,458.30
3.70
2,216
10.98
55.04

Automatic Screeners on ScanX

Community
5% near 52 Week High
Community
Resistance 1 Breached
Growth Rate
Revenue Growth
12.35 %
Net Income Growth
19.36 %
Cash Flow Change
12.72 %
ROE
1.64 %
ROCE
-3.02 %
EBITDA Margin (Avg.)
1.96 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
408
444
398
435
459
475
445
447
545
452
604
554
619
613
605
627
786
811
796
767
902
889
852
878
1,010
1,011
972
964
1,109
1,100
1,083
Expenses
326
354
304
353
350
356
339
362
367
334
377
405
442
466
473
500
612
625
618
599
664
638
621
664
724
730
709
723
793
775
769
EBITDA
82
90
94
81
109
119
106
85
178
119
227
149
177
146
133
127
174
186
178
168
238
251
231
215
286
281
263
241
315
325
314
Operating Profit %
20 %
19 %
20 %
16 %
22 %
22 %
21 %
18 %
30 %
25 %
31 %
23 %
27 %
21 %
21 %
20 %
22 %
23 %
22 %
21 %
26 %
28 %
26 %
23 %
28 %
27 %
26 %
24 %
28 %
29 %
28 %
Depreciation
15
15
15
12
16
16
17
17
17
18
17
17
18
16
17
22
26
28
28
32
31
32
34
41
41
42
42
46
43
44
45
Interest
1
1
1
1
1
1
1
1
4
2
1
1
1
1
1
2
6
8
8
14
12
10
13
9
6
2
3
2
1
1
2
Profit Before Tax
66
75
78
68
92
102
88
67
157
99
209
132
158
129
114
103
142
150
141
123
194
209
184
165
240
237
218
193
272
279
267
Tax
21
23
28
22
30
8
22
17
38
25
54
31
39
32
30
18
37
39
35
35
52
58
50
38
63
62
56
47
69
71
69
Net Profit
46
52
50
47
62
94
66
50
120
74
154
101
119
98
84
85
105
111
106
88
142
151
134
126
177
175
163
146
202
208
198
EPS in ₹
5.46
6.14
6.07
5.68
7.73
11.67
8.26
6.30
15.45
9.55
19.94
13.02
15.38
12.65
10.85
10.98
13.59
14.37
13.72
11.33
9.20
9.72
8.62
8.22
11.39
11.24
10.46
9.36
12.99
13.29
12.63
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,487
1,648
1,674
1,765
1,792
1,821
2,238
2,607
3,554
3,994
4,274
Fixed Assets
329
440
679
640
621
651
634
1,277
1,901
2,004
1,968
Current Assets
901
816
795
1,047
1,051
1,073
1,553
1,253
1,528
1,853
1,923
Capital Work in Progress
55
135
4
17
15
16
26
19
55
76
63
Investments
367
479
411
434
457
403
678
13
206
388
345
Other Assets
737
594
580
674
699
750
901
1,299
1,392
1,525
1,897
Total Liabilities
1,487
1,648
1,674
1,765
1,792
1,821
2,238
2,607
3,554
3,994
4,274
Current Liabilities
460
431
281
275
244
313
345
384
554
868
632
Non Current Liabilities
33
31
27
46
65
69
79
85
519
203
208
Total Equity
995
1,186
1,366
1,444
1,483
1,438
1,813
2,139
2,480
2,923
3,433
Reserve & Surplus
978
1,167
1,347
1,425
1,464
1,420
1,794
2,119
2,465
2,908
3,418
Share Capital
17
17
17
17
16
16
16
16
16
16
16
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
13
15
-28
43
11
-6
-3
34
20
11
27
Investing Activities
-112
-26
-45
-21
-28
24
-231
2
-962
-404
-296
Operating Activities
127
140
201
123
194
276
315
170
626
801
903
Financing Activities
-1
-100
-184
-60
-156
-306
-87
-138
357
-386
-580
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Jan 2026
Promoter
55.91 %
55.91 %
55.91 %
54.00 %
54.00 %
54.00 %
53.96 %
53.95 %
53.93 %
53.91 %
53.86 %
53.83 %
53.78 %
53.77 %
53.74 %
53.66 %
47.84 %
47.73 %
47.56 %
47.55 %
48.78 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.05 %
0.00 %
11.06 %
12.17 %
13.63 %
14.64 %
18.30 %
17.77 %
15.30 %
14.88 %
14.56 %
DIIs
12.41 %
12.32 %
14.76 %
16.03 %
16.67 %
17.52 %
18.08 %
18.54 %
19.08 %
18.65 %
18.58 %
17.97 %
18.38 %
17.62 %
16.81 %
16.41 %
18.72 %
19.63 %
22.83 %
23.36 %
22.71 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
20.50 %
19.69 %
17.64 %
18.38 %
17.87 %
17.37 %
16.94 %
16.70 %
15.98 %
15.66 %
15.34 %
15.17 %
14.69 %
14.38 %
13.87 %
13.42 %
13.28 %
13.04 %
12.47 %
12.37 %
12.03 %
Others
11.18 %
12.08 %
11.70 %
11.58 %
11.47 %
11.10 %
11.02 %
10.81 %
11.00 %
11.79 %
2.17 %
13.03 %
2.09 %
2.05 %
1.94 %
1.87 %
1.86 %
1.83 %
1.84 %
1.85 %
1.92 %
No of Share Holders
0
65,715
70,740
71,788
64,861
61,314
60,268
58,629
56,633
55,965
60,817
63,230
63,892
66,953
62,743
62,081
63,948
70,064
71,957
69,338
68,966

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 1 2 5 11 16.5 16.5 17.75 12.25 15.5 0.00
Dividend Yield (%) 0.64 1.1 1.96 1.75 2.1 1.67 1.08 0.75 0.82 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Feb 2026 DIVIDEND Dividend
₹ 12.70 /share
 11 Feb 2026 1,893.35 1,882.70
22 Feb 2021 DIVIDEND Dividend
₹ 8.50 /share
 18 Feb 2021 520.90 555.25
02 Sept 2021 DIVIDEND Dividend
₹ 8.00 /share
 01 Sept 2021 770.03 850.15
24 Feb 2022 DIVIDEND Dividend
₹ 8.50 /share
 23 Feb 2022 852.88 804.93
17 Aug 2022 DIVIDEND Dividend
₹ 8.00 /share
 12 Aug 2022 785.18 931.68
18 Feb 2023 DIVIDEND Dividend
₹ 8.50 /share
 17 Feb 2023 1,008.50 982.73
17 Aug 2023 DIVIDEND Dividend
₹ 9.25 /share
 17 Aug 2023 976.00 1,315.08
24 May 2023 SPLIT Split
1:2
 18 Sept 2023 976.00 976.00
16 Feb 2024 DIVIDEND Dividend
₹ 5.50 /share
 16 Feb 2024 1,708.40 1,664.30
14 Aug 2024 DIVIDEND Dividend
₹ 6.75 /share
 14 Aug 2024 1,832.55 1,941.60
21 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 21 Aug 2024 1,788.80 1,942.60
06 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 06 Nov 2024 1,895.75 1,852.00
04 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 04 Feb 2025 1,805.05 1,714.10
08 Feb 2025 DIVIDEND Dividend
₹ 8.50 /share
 07 Feb 2025 1,714.10 1,673.75
14 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 14 May 2025 1,658.70 1,579.85
30 Jul 2025 DIVIDEND Dividend
₹ 7.00 /share
 30 Jul 2025 1,579.85 1,802.60
30 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Jul 2025 1,651.85 1,802.60
06 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 06 Aug 2025 1,612.55 1,692.45
11 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 11 Nov 2025 1,708.80 1,813.40
16 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 16 Jan 2026 1,818.60 1,894.20

Announcements

Announcement under Regulation 30 (LODR)-Cessation2 days ago
Announcement under Regulation 30 (LODR)-Cessation4 days ago
Intimation Of Record Date4 days ago
Board Meeting Outcome for Outcome Of Meeting Of The Board Of Directors4 days ago
Change In Key Managerial Personnel - Letter Of Resignation4 days ago
Shifting Of Registered Office5 days ago
Board Meeting Intimation for Intimation Under Regulation 29 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 20157 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS10 days ago
Announcement under Regulation 30 (LODR)-Change in ManagementJan 29, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 24, 2026
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Jan 24, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 22, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 22, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 21, 2026
Corrigendum To The Outcome Of The First Board Meeting Held On 21 January 2026Jan 21, 2026
Disclosure Under Regulation 31A(10)(Ii) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations").Jan 21, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateJan 21, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 21 January 2026Jan 21, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 21, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 19, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 17, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 16, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 16, 2026
Board Meeting Outcome for Outcome Of Meeting Of Board Of DirectorsJan 16, 2026
Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 07, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 05, 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Receipt Of OrderDec 30, 2025
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter And Nine Months Ending On December 31 2025Dec 29, 2025
Closure of Trading WindowDec 29, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 24, 2025
DJSI (Dow Jones Sustainable Index) ESG Score ReleaseDec 22, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Receipt Of OrderDec 16, 2025
Updates on Open OfferDec 09, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 06, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 23, 2025
Updates on Open OfferNov 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 14, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 11, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 11, 2025
Board Meeting Outcome for Outcome Of Board MeetingNov 11, 2025
Letter of OfferNov 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 31, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 31, 2025
4Th Sustainability (ESG) ReportOct 24, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Baroda BNP Paribas Health and Wellness Fund Direct-Growth
0.00%
-100000
-3.10%
-2.90%
Helios Mid Cap Fund Direct-Growth
0.00%
-99780
-1.57%
-1.19%
Helios Small Cap Fund Direct-Growth
0.00%
-50790
-1.49%
-1.50%
DSP Nifty500 Flexicap Quality 30 Index Fund Direct - Growth
0.00%
-9997
-1.67%
-3.41%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
-9102
-0.74%
-0.72%
Sundaram Long Term Tax Advantage Fund Series III Direct - Growth
0.00%
-5362
-2.88%
-2.77%
WhiteOak Capital Equity Savings Fund Direct - Growth
0.00%
-4388
-0.36%
-0.23%
Sundaram Long Term Tax Advantage Fund Series IV Direct - Growth
0.00%
-2376
-1.94%
-1.87%
DSP Nifty Smallcap 250 Index Fund Direct - Growth
0.00%
-314
-0.73%
0.00%
Navi Nifty MidSmallcap 400 Index Fund Direct - Growth
0.00%
-156
-0.25%
0.00%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.08%
5
0.00%
0.01%
Invesco India Smallcap Fund Direct - Growth
0.00%
0
0.00%
0.00%
Axis Large & Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Kotak Balanced Advantage Fund Direct - Growth
0.00%
0
0.00%
-0.36%
Axis Equity Savings Fund Direct-Growth
0.00%
0
0.00%
-0.62%
Axis India Manufacturing Fund Direct-Growth
0.00%
0
0.00%
-1.14%
Kotak Contra Fund Direct-Growth
0.00%
0
0.00%
-0.89%
Axis Midcap Direct Plan-Growth
0.00%
0
0.00%
-0.56%
Axis Multi Asset Allocation Direct Plan -Growth
0.00%
0
0.00%
-0.59%
Axis Multicap Fund Direct-Growth
0.00%
0
0.00%
-0.66%
Axis Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
-0.07%
Axis Nifty Smallcap 50 Index Fund Direct-Growth
0.00%
0
0.00%
-1.98%
Axis Retirement Fund - Conservative Plan Direct-Growth
0.88%
0
0.00%
0.07%
Axis Small Cap Fund Direct-Growth
0.00%
0
0.00%
-2.05%
Axis Value Fund Direct-Growth
0.00%
0
0.00%
-0.77%

Technical Indicators

RSI(14)
Neutral
53.58
ATR(14)
Volatile
44.10
STOCH(9,6)
Neutral
64.46
STOCH RSI(14)
Oversold
18.18
MACD(12,26)
Bearish
-3.86
ADX(14)
Weak Trend
16.70
UO(9)
Bearish
57.14
ROC(12)
Downtrend But Slowing Down
-0.99
WillR(14)
Neutral
-31.43
Bearish
4
Neutral
4
Bullish
1

About J B Chemicals and Pharmaceuticals

J.B. Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1976. It manufactures and markets a range of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. The company specializes in gastroenterology, hypertension, and dermatology, with additional focus on nephrology, respiratory, virology, diabetes, and nicotine replacement therapy. Key brands...more
Website
https://www.jbpharma.com
Chairperson NameArun Duggal
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104